Human Drugs --> Information for Healthcare Professionals
SEARCH: FDA Site   |   Drug Name  
Information for Consumers  |  Information for Healthcare Professionals  |  Information for Industry
Information for Healthcare Professionals
Browse By Subject

black rule


Drugs in the News

September 12. Genentech informs healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML). MedWatch Safety Information

September 5. FDA posts quarterly report of potential safety issues. FDA News

September 4. FDA announces that manufacturers of TNF-blocker drugs (Cimzia, Enbrel, Humira, and Remicade) must highlight the risk of fungal and serious opportunistic infections. Drug Information; FDA News

August 25. FDA updates the Information for Healthcare Professionals sheet for Tysabri (natalizumab). Drug Information

August 21. FDA issues an Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia). Drug Information

Previous News Items

Featured Items

Search for Brand Name and Generic Drugs
current and archival drug labels, drug approval histories, and more

current drug labeling
More information for health professionals from FDA
 I want to ...

find a generic equivalent to a drug

report adverse events or product problems

sign up for FDA updates

find career opportunities at FDA